-Phill B Jones Researcher Activity Profile

Research Author Detailed Information 

Phill B Jones Publication Rate By Year

Phill B Jones has published 2 paper(s) in 2003, 2 paper(s) in 2006, 19 paper(s) in 2007, 6 paper(s) in 2008, for a total of 29 research publications in total.

Phill B Pb Jones Author Information

LAST NAME: jones

FIRST NAME: Phill B

INITIALS: pb

AFFILIATION:

Papers

Phill B Jones's Publication Record

1. Interaction between presenilin 1 and ubiquilin 1 as detected by fluorescence lifetime imaging microscopy and a high-throughput fluorescent plate reader. Year Published: 2006
Alzheimer's Disease Research Laboratory, Harvard Medical School, Charlestown, Massachusetts 02129, USA.
2. Ubiquilin 1 modulates amyloid precursor protein trafficking and Abeta secretion. Year Published: 2006
Genetics and Aging Research Unit, MassGeneral Institute for Neurodegenerative Disease, Massachusetts General Hospital, Charlestown, MA 02129, USA.
3. A multicompartment vascular model for inferring baseline and functional changes in cerebral oxygen metabolism and arterial dilation. Year Published: 2007
Athinoula A Martinos Center for Biomedical Imaging, Massachusetts General Hospital, Charlestown, Massachusetts, USA. thuppert@nmr.mgh.harvard.edu
4. Normobaric hyperoxia improves cerebral blood flow and oxygenation, and inhibits peri-infarct depolarizations in experimental focal ischaemia. Year Published: 2007
Stroke and Neurovascular Regulation Laboratory, Department of Radiology, Massachusetts General Hospital, Harvard Medical School, Charlestown, MA 02129, USA.
5. Substance use in a population-based clinic sample of people with first-episode psychosis. Year Published: 2007
Department of Psychiatry, Box 189, University of Cambridge, UK. jhb32@cam.ac.uk
6. Cost-effectiveness of first- v. second-generation antipsychotic drugs: results from a randomised controlled trial in schizophrenia responding poorly to previous therapy. Year Published: 2007
Division of Psychiatry, University of Manchester, Rawnsley Building, MRI, Oxford Road, Manchester M13 9WL, UK. Linda.davies@manchester.ac.uk
7. Age-dependent cerebrovascular dysfunction in a transgenic mouse model of cerebral amyloid angiopathy. Year Published: 2007
Stroke and Neurovascular Regulation Laboratory, Department of Radiology, Massachusetts General Hospital, Harvard Medical School, Charlestown, MA 02129, USA.
8. Neighbourhood-level effects on psychoses: re-examining the role of context. Year Published: 2007
Department of Psychiatry, University of Cambridge, Cambridge, UK. jbk25@cam.ac.uk
9. Impaired spine stability underlies plaque-related spine loss in an Alzheimer's disease mouse model. Year Published: 2007
MassGeneral Institute for Neurodegenerative Disease, Department of Neurology, Massachusetts General Hospital/ Harvard Medical School, Charlestown, Massachusetts, USA.
10. A longitudinal typology of symptoms of depression and anxiety over the life course. Year Published: 2007
Department of Psychiatry, University of Cambridge, Addenbrooke's Hospital, Cambridge, UK.
11. Prevalence of depression in older people in England and Wales: the MRC CFA Study. Year Published: 2007
Department of Public Health and Primary Care, Cambridge University, UK.
12. Minor physical anomalies in patients with first-episode psychosis: their frequency and diagnostic specificity. Year Published: 2007
Nottinghamshire Healthcare NHS Trust, Nottingham, UK.
13. Cost-effectiveness of first- v. second-generation antipsychotic drugs: results from a randomised controlled trial in schizophrenia responding poorly to previous therapy. Year Published: 2007
Division of Psychiatry, University of Manchester, Rawnsley Building, MRI, Oxford Road, Manchester M13 9WL, UK. Linda.davies@manchester.ac.uk
14. Prevalence of depression in older people in England and Wales: the MRC CFA Study. Year Published: 2007
Department of Public Health and Primary Care, Cambridge University, UK. fm257@cam.ac.uk
15. Substance use in a population-based clinic sample of people with first-episode psychosis. Year Published: 2007
Department of Psychiatry, Box 189, University of Cambridge, UK. jhb32@cam.ac.uk
16. Grey matter abnormalities in first-episode schizophrenia and affective psychosis. Year Published: 2007
Department of Psychology, University of Westminster, 309 Regent Street, London W1B 2UW, UK. k.d.morgan@wmin.ac.uk
17. Duration of prodromal phase and severity of volumetric abnormalities in first-episode psychosis. Year Published: 2007
King's College London, Institute of Psychiatry, London, UK.
18. In vivo imaging reveals dissociation between caspase activation and acute neuronal death in tangle-bearing neurons. Year Published: 2008
MassGeneral Institute for Neurodegenerative Disease, Massachusetts General Hospital, Harvard Medical School, Charlestown, Massachusetts 02129, USA.
19. A longitudinal typology of symptoms of depression and anxiety over the life course. Year Published: 2007
Department of Psychiatry, University of Cambridge, Addenbrooke's Hospital, Cambridge, UK.
20. Cannabis use and risk of psychotic or affective mental health outcomes: a systematic review. Year Published: 2007
Academic Unit of Psychiatry, University of Bristol, Bristol, UK.
21. Neighbourhood-level effects on psychoses: re-examining the role of context. Year Published: 2007
Department of Psychiatry, University of Cambridge, Cambridge, UK. jbk25@cam.ac.uk
22. Evidence for an influence of chemokine ligand 3-like 1 (CCL3L1) gene copy number on susceptibility to rheumatoid arthritis. Year Published: 2008
Department of Biochemistry, University of Otago, PO Box 56, Dunedin, New Zealand.
23. Associations between early development and outcome in schizophrenia - A 35-year follow-up of the Northern Finland 1966 Birth Cohort. Year Published: 2008
Department of Psychiatry, University of Oulu, Finland, P.O. BOX 5000, 90014 University of Oulu, Finland.
24. In vivo imaging reveals dissociation between caspase activation and acute neuronal death in tangle-bearing neurons. Year Published: 2008
MassGeneral Institute for Neurodegenerative Disease, Massachusetts General Hospital, Harvard Medical School, Charlestown, Massachusetts 02129, USA.
25. The European Schizophrenia Outpatient Health Outcomes Study: baseline findings across country and treatment. Year Published: 2003
Research and Development Unit, Sant Joan de Déu-SSM, Sant Boi, Barcelona, Spain. 27652jha@comb.es
26. The Clinical Global Impression-Schizophrenia scale: a simple instrument to measure the diversity of symptoms present in schizophrenia. Year Published: 2003
Research and Development Unit, Sant Joan de Déu-SSM, Sant Boi, Barcelona, Spain. 27652jha@comb.es
27. Minor physical anomalies in patients with first-episode psychosis: their frequency and diagnostic specificity. Year Published: 2007
Nottinghamshire Healthcare NHS Trust, Nottingham, UK. Tuhina.Lloyd@nottingham.ac.uk
28. Disease Activity Score 28-ESR bears a similar relationship to treatment decisions across different rheumatologists, but misclassification is too frequent to replace physician judgement. Year Published: 2008
Department of Medicine, University of Otago Wellington, PO Box 7343, Wellington 6242, New Zealand. will.taylor@otago.ac.nz
29. Associations between early development and outcome in schizophrenia--A 35-year follow-up of the Northern Finland 1966 Birth Cohort. Year Published: 2008
Department of Psychiatry, University of Oulu, Finland, P.O. BOX 5000, 90014 University of Oulu, Finland. erika.lauronen@oulu.fi